Pfizer to apply for approval for giving vaccine to kids - report

Wednesday, 15. September 2021 01:34

Pfizer Inc. is planning to ask the United States Food and Drug Administration (FDA) to approve the use of the vaccine against COVID-19 it developed with BioNTech for use in children between the ages of five and eleven, the Financial Times reported on Tuesday.

According to sources familiar with the matter, the company will request approval in November.

The report comes shortly after the United Kingdom's health authorities recommended the vaccine to be used in children between the ages of 12 and 16.

Related Links: BioNTech SEPfizer Inc.
Breaking the News / JR